- Home
- CLDI vs GLBS Comparison
CLDI vs GLBS Comparison
Compare CLDI & GLBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- GLBS
- Stock Information
- Founded
- CLDI 2014
- GLBS 2006
- Country
- CLDI United States
- GLBS Greece
- Employees
- CLDI N/A
- GLBS N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- GLBS Marine Transportation
- Sector
- CLDI Health Care
- GLBS Consumer Discretionary
- Exchange
- CLDI Nasdaq
- GLBS Nasdaq
- Market Cap
- CLDI 20.2M
- GLBS 21.4M
- IPO Year
- CLDI N/A
- GLBS 2007
- Fundamental
- Price
- CLDI $1.60
- GLBS $1.07
- Analyst Decision
- CLDI
- GLBS Strong Buy
- Analyst Count
- CLDI 0
- GLBS 1
- Target Price
- CLDI N/A
- GLBS $3.00
- AVG Volume (30 Days)
- CLDI 484.3K
- GLBS 37.0K
- Earning Date
- CLDI 11-11-2025
- GLBS 09-12-2025
- Dividend Yield
- CLDI N/A
- GLBS N/A
- EPS Growth
- CLDI N/A
- GLBS N/A
- EPS
- CLDI N/A
- GLBS N/A
- Revenue
- CLDI N/A
- GLBS $35,776,000.00
- Revenue This Year
- CLDI N/A
- GLBS $5.01
- Revenue Next Year
- CLDI N/A
- GLBS $27.86
- P/E Ratio
- CLDI N/A
- GLBS N/A
- Revenue Growth
- CLDI N/A
- GLBS 17.92
- 52 Week Low
- CLDI $1.51
- GLBS $0.99
- 52 Week High
- CLDI $46.68
- GLBS $2.21
- Technical
- Relative Strength Index (RSI)
- CLDI 30.60
- GLBS 53.48
- Support Level
- CLDI $1.51
- GLBS $1.01
- Resistance Level
- CLDI $1.68
- GLBS $1.09
- Average True Range (ATR)
- CLDI 0.10
- GLBS 0.04
- MACD
- CLDI 0.14
- GLBS 0.01
- Stochastic Oscillator
- CLDI 22.97
- GLBS 72.22
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About GLBS Globus Maritime Limited
Globus Maritime Ltd is a dry bulk shipping company that provides marine transportation services internationally. The company owns, operates, and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina, and other dry bulk cargo. Its operations are managed by its subsidiary which also provides in-house commercial and technical management for its vessels and also offers consulting services for an affiliated ship management company. It generates maximum revenues by charging customers for the use of vessels to transport dry bulk commodities.